Carnegie Investment Counsel’s Hims & Hers Health HIMS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIMS
VPM
VCM
DE
Carnegie Investment Counsel's HIMS Position: Q1 2026 in Review
Carnegie Investment Counsel sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 93,334 shares — an estimated $3.03M sold.
Carnegie Investment Counsel first reported a position in HIMS in Q3 2024 and held it in 6 quarters. The position peaked at $17.2M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.
- Carnegie Investment Counsel reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
- Carnegie Investment Counsel sold 93,334 Hims & Hers Health shares in Q1 2026, an estimated $3.03M.
- Carnegie Investment Counsel first reported a position in Hims & Hers Health in Q3 2024 and held it in 6 quarters.
- Carnegie Investment Counsel's Hims & Hers Health position peaked at $17.2M in Q3 2025.
- 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.
Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.